Juno taps Trianni for mAb discovery platform
Juno Therapeutics has signed a licensing agreement with Trianni for use of its monoclonal antibody (mAb) discovery platform.
Archives for October 19, 2017
Cost, risk, on-time and in-full: Defining value in the customer-supplier relationship
Pharmaceutical companies are more likely than their suppliers to cite cost improvement over time as the most effective metric for measuring supplier performance, according to a recent report.
BioProduction Congress Dublin 2017
HPRA raises Brexit concerns: GMP mutual recognition & member state status
Irish regulators say it is still not clear how Brexit will affect companies that make drugs in the UK, raising issues like MA status and mutual inspection agreements between the EMA and US FDA as areas of concern.
Locate to deliver personalised diabetes therapy through UK gov grant
Locate Therapeutics has received a grant to demonstrate how its synthetic peptide-based intracellular platform can deliver personalised medicines.
Rutgers and NJII to set up continuous manufacturing institute
The New Jersey Innovation Institute and Rutgers University have teamed up to establish an institute to promote the development of continuous manufacturing technologies for drug production.
news in brief
STA to open catalyst screening centre in Changzhou in November
STA Pharmaceutical Co is setting up a metal catalyst-screening center at its facility in Changzhou, China.
Pfizer pulls batches of antibiotic in Australia over anaphylaxis risk
Pfizer has recalled 10 batches of gentamicin in Australia because of problems with an API supplied by a third party.